About Celleration
Celleration is a company based in Eden Prairie (United States) founded in 1999 was acquired by Alliqua in February 2015. Celleration has raised $70.57 million across 7 funding rounds from investors including Indiana University Health, Alliqua and Affinity Capital Management. The company has 43 employees as of December 31, 2014. Celleration operates in a competitive market with competitors including Piomic, Sky Medical Technology, Intelligent Implants, Thereson and Biofisica, among others.
- Headquarter Eden Prairie, United States
- Employees 43 as on 31 Dec, 2014
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Celleration Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$70.57 M (USD)
in 7 rounds
-
Latest Funding Round
$6.42 M (USD), Series E
Jan 04, 2013
-
Investors
Indiana University Health
& 12 more
-
Employee Count
43
as on Dec 31, 2014
-
Acquired by
Alliqua
(Feb 02, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Celleration
Celleration has successfully raised a total of $70.57M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $6.42 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Celleration
Celleration has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Indiana University Health, Alliqua and Affinity Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia
|
Locked | Locked | Locked | |
|
A venture fund focused on medical sector investments is managed.
|
Locked | Locked | Locked |
Investor details for Celleration
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celleration
Investment portfolio details for Celleration
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celleration
Detailed financials for Celleration
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celleration Comparisons
Peer comparison for Celleration
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celleration
Celleration operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Piomic, Sky Medical Technology, Intelligent Implants, Thereson and Biofisica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A non-invasive electroceutical device for chronic wound treatment is developed.
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
Develops smart implants to accelerate and monitor bone growth in orthopedics.
|
|
| Locked | Locked | Locked |
Therapeutic Magnetic Resonance based device with applications in wound care and orthopaedics
|
|
| Locked | Locked | Locked |
Develops electrical stimulation devices to promote wound healing.
|
Detailed competitors of Celleration
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celleration
Complete news archive for Celleration
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celleration
Celleration was founded in 1999 and raised its 1st funding round 5 years after it was founded.
Celleration is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Celleration is a funded company, having raised a total of $70.57M across 7 funding rounds to date.
As of Dec 31, 2014, the latest employee count at Celleration is 43.
Founded in 1999 and headquartered in Eden Prairie, United States, Celleration operates as a medical device company focused on ultrasound technology for wound treatment. Proprietary low-frequency ultrasound is delivered via a saline mist through the MIST Therapy System, which received FDA 510(k) clearance in 2005 for promoting wound healing. Treatments have been administered over one million times in the United States and United Kingdom, serving more than 65,000 patients.
Celleration's top competitors include Sky Medical Technology, Piomic and BioElectronics Corporation.
Celleration has 13 investors. Key investors include Indiana University Health, Alliqua, Affinity Capital Management, Venture Investors, and Triathlon Medical Ventures.